Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy: Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26765438)

Published in Medicine (Baltimore) on January 01, 2016

Authors

Sehhoon Park1, Hwi Young Kim, Haeryoung Kim, Jin Hyun Park, Jung Ho Kim, Ki Hwan Kim, Won Kim, In Sil Choi, Yong Jin Jung, Jin-Soo Kim

Author Affiliations

1: From the Department of Internal Medicine (SP), Seoul National University Hospital, Seoul; Department of Internal Medicine (HYK, JHP, KHK, WK, ISC, YJJ, J-SK), Seoul National University Boramae Medical Center, Seoul; Department of Pathology (HK), Seoul National University Bundang Hospital, Bundang-gu, Seongnam; and Department of Pathology (JHK), Seoul National University Boramae Medical Center, Seoul, Korea.

Articles cited by this

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med (2004) 18.93

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol (2000) 16.83

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet (2008) 9.92

Liver biopsy. N Engl J Med (2001) 9.91

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet (2012) 6.83

Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol (2009) 5.42

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol (2004) 4.78

Noninvasive assessment of liver fibrosis. Hepatology (2010) 3.86

Noninvasive measures of liver fibrosis. Hepatology (2006) 2.80

Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol (2007) 2.75

Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol (2006) 2.71

Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol (2005) 2.66

A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology (2005) 2.38

Diagnosis and quantitation of fibrosis. Gastroenterology (2008) 2.20

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer (2007) 2.12

Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology (2009) 2.10

Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg (2008) 2.10

Noninvasive monitoring of patients with chronic hepatitis C. Hepatology (2002) 2.08

High liver fibrosis index FIB-4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers. Hepatology (2015) 1.65

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials. Lancet Oncol (2014) 1.57

Prediction of cancer incidence and mortality in Korea, 2014. Cancer Res Treat (2014) 1.55

Empiric comparison of multivariate analytic techniques: advantages and disadvantages of recursive partitioning analysis. J Chronic Dis (1984) 1.49

Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol (2010) 1.36

Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol (2007) 1.34

Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer. Cancer Chemother Pharmacol (2007) 1.11

Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index. Dig Dis Sci (2003) 1.08

Sinusoidal obstruction syndrome. Clin Liver Dis (2010) 0.97

Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: comparison of the APRI and FIB-4 index. Clin Chim Acta (2008) 0.97

Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation. Bone Marrow Transplant (2001) 0.94

Evaluation and management of hepatic injury induced by oxaliplatin-based chemotherapy in patients with hepatic resection for colorectal liver metastasis. Hepatol Res (2013) 0.91

Splenomegaly in FOLFOX-naïve stage IV or recurrent colorectal cancer patients due to chemotherapy-associated hepatotoxicity can be predicted by the aspartate aminotransferase to platelet ratio before chemotherapy. Int J Clin Oncol (2011) 0.88

Splenic volume may be a useful indicator of the protective effect of bevacizumab against oxaliplatin-induced hepatic sinusoidal obstruction syndrome. Eur J Surg Oncol (2013) 0.87

Chemotherapy-associated hepatopathy in korean colorectal cancer liver metastasis patients: oxaliplatin-based chemotherapy and sinusoidal injury. Korean J Pathol (2012) 0.86

Diagnosis of liver fibrosis: present and future. Semin Liver Dis (2015) 0.84

Hepatic regeneration is decreased in a rat model of sinusoidal obstruction syndrome. J Surg Oncol (2009) 0.84

Assessment of the presence and severity of esophagogastric varices by splenic index in patients with liver cirrhosis. J Comput Assist Tomogr (2000) 0.81

Noninvasive ratio indexes to evaluate fibrosis staging in chronic hepatitis C: role of platelet count/spleen diameter ratio index. J Intern Med (2006) 0.80

Articles by these authors

Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol (2013) 14.28

Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly. Genome Res (2009) 8.69

Targeted chromosomal deletions in human cells using zinc finger nucleases. Genome Res (2009) 6.24

Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res (2013) 6.19

Knockout mice created by TALEN-mediated gene targeting. Nat Biotechnol (2013) 4.31

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol (2005) 4.03

Human zinc fingers as building blocks in the construction of artificial transcription factors. Nat Biotechnol (2003) 4.03

Genome editing with modularly assembled zinc-finger nucleases. Nat Methods (2010) 3.79

Surrogate reporters for enrichment of cells with nuclease-induced mutations. Nat Methods (2011) 3.22

Precision genome engineering with programmable DNA-nicking enzymes. Genome Res (2012) 3.05

Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma. J Hepatol (2012) 2.94

A library of TAL effector nucleases spanning the human genome. Nat Biotechnol (2013) 2.87

Targeted chromosomal duplications and inversions in the human genome using zinc finger nucleases. Genome Res (2011) 2.85

MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin Cancer Res (2013) 2.71

Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics (2014) 2.54

Preassembled zinc-finger arrays for rapid construction of ZFNs. Nat Methods (2011) 2.54

Heritable gene knockout in Caenorhabditis elegans by direct injection of Cas9-sgRNA ribonucleoproteins. Genetics (2013) 2.44

Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology (2012) 2.44

Evaluation of Query Expansion Using MeSH in PubMed. Inf Retr Boston (2009) 2.39

Electrical manipulation of nanofilaments in transition-metal oxides for resistance-based memory. Nano Lett (2009) 2.30

Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases. Genome Res (2013) 2.28

Safety evaluation of freehand lateral mass screw fixation in the subaxial cervical spine: evaluation of 1256 screws. Spine (Phila Pa 1976) (2015) 1.98

Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. J Hepatol (2012) 1.94

Abbreviation definition identification based on automatic precision estimates. BMC Bioinformatics (2008) 1.91

Optimal training sets for Bayesian prediction of MeSH assignment. J Am Med Inform Assoc (2008) 1.86

COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci U S A (2004) 1.85

The effect of basic life support education on laypersons' willingness in performing bystander hands only cardiopulmonary resuscitation. Resuscitation (2010) 1.84

Evaluating relevance ranking strategies for MEDLINE retrieval. J Am Med Inform Assoc (2008) 1.82

HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer (2007) 1.80

Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft. Liver Transpl (2009) 1.79

A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neurosci Lett (2004) 1.79

Recommended immunization schedule for children and adolescents: the Korean Pediatric Society, 2013. Korean J Pediatr (2013) 1.73

Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival. Radiology (2011) 1.71

Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6. J Med Chem (2008) 1.70

TALENs and ZFNs are associated with different mutation signatures. Nat Methods (2013) 1.66

Phenotypic alteration of eukaryotic cells using randomized libraries of artificial transcription factors. Nat Biotechnol (2003) 1.65

High liver fibrosis index FIB-4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers. Hepatology (2015) 1.65

DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Int J Mol Med (2007) 1.59

Comparison of time-frequency responses and the event-related potential to auditory speech stimuli in human cortex. J Neurophysiol (2009) 1.54

Serum Tumor Markers Provide Refined Prognostication in Selecting Liver Transplantation Candidate for Hepatocellular Carcinoma Patients Beyond the Milan Criteria. Ann Surg (2016) 1.52

Risk of hepatitis B virus reactivation in patients with asthma or chronic obstructive pulmonary disease treated with corticosteroids. Respirology (2010) 1.51

A case of unilateral renal cystic disease. Nephrology (Carlton) (2004) 1.45

Eupatilin attenuates bile acid-induced hepatocyte apoptosis. J Gastroenterol (2006) 1.44

[Efficacy of entecavir switching therapy in chronic hepatitis B patients with clevudine-induced myopathy]. Korean J Gastroenterol (2013) 1.43

Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: a multicenter, prospective, naturalistic, open-label trial. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.43

Therapeutic granulocyte transfusions for the treatment of febrile neutropenia in patients with hematologic diseases: a 10-year experience at a single institute. Cytotherapy (2010) 1.43

Common cerebral networks associated with distinct deep brain stimulation targets for cluster headache. Cephalalgia (2013) 1.43

Visceral adipose tissue area as an independent risk factor for elevated liver enzyme in nonalcoholic fatty liver disease. Medicine (Baltimore) (2015) 1.41

Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma. Clin Cancer Res (2008) 1.41

Visceral adipose tissue area is an independent risk factor for hepatic steatosis. J Gastroenterol Hepatol (2007) 1.41

Pleural Effusion in Multiple Myeloma: Characteristics and Practice Patterns. Acta Haematol (2017) 1.39

Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats. J Pharmacol Exp Ther (2011) 1.39

Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc Natl Acad Sci U S A (2004) 1.34

The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am J Gastroenterol (2009) 1.33

The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. Neurosurg Focus (2011) 1.33

Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis (2009) 1.32

Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis. J Hepatol (2010) 1.30

SPELLING CORRECTION IN THE PUBMED SEARCH ENGINE. Inf Retr Boston (2006) 1.29

A repeatedly recurrent desmoplastic ameloblastoma after removal and allobone graft: Radiographic features compared with histological changes. Imaging Sci Dent (2013) 1.23

Proteome analysis of hepatocellular carcinoma. Biochem Biophys Res Commun (2002) 1.23

Sagittal alignment of the cervical spine after the laminoplasty. Spine (Phila Pa 1976) (2007) 1.22

Resistive switching multistate nonvolatile memory effects in a single cobalt oxide nanowire. Nano Lett (2010) 1.20

Intraspecific molecular phylogeny, genetic variation and phylogeography of Reticulitermes speratus (Isoptera: Rhinotermitidae). Mol Cells (2006) 1.19

Friction anisotropy-driven domain imaging on exfoliated monolayer graphene. Science (2011) 1.19

SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol (2011) 1.19

Magnetic separation and antibiotics selection enable enrichment of cells with ZFN/TALEN-induced mutations. PLoS One (2013) 1.17

Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis. Hepatology (2007) 1.15

New gene selection method for classification of cancer subtypes considering within-class variation. FEBS Lett (2003) 1.15

The radial artery superficial palmar branch flap: a modified free thenar flap with constant innervation. J Reconstr Microsurg (2010) 1.15

Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol (2011) 1.15

Temozolomide and other potential agents for the treatment of glioblastoma multiforme. Neurosurg Clin N Am (2012) 1.13

Phenotypic alteration and target gene identification using combinatorial libraries of zinc finger proteins in prokaryotic cells. J Bacteriol (2005) 1.13

Reliability and validity of the Korean version of the Impact of Event Scale-Revised. Compr Psychiatry (2008) 1.13

Endoscopic band ligation and endoscopic hemoclip placement for patients with Mallory-Weiss syndrome and active bleeding. World J Gastroenterol (2008) 1.13

Using MEDLINE as a knowledge source for disambiguating abbreviations and acronyms in full-text biomedical journal articles. J Biomed Inform (2006) 1.12

Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. J Neurosurg (2009) 1.12

Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes. Biochem Biophys Res Commun (2007) 1.12

Custom DNA-binding proteins and artificial transcription factors. Curr Top Med Chem (2003) 1.11

Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes. Nephrol Dial Transplant (2006) 1.11

Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules. J Korean Med Sci (2007) 1.11

E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide. Breast Cancer Res Treat (2003) 1.11

Clinical and histological features of nonalcoholic fatty liver disease in children. Dig Dis Sci (2009) 1.09

Simultaneous determination of amoxicillin and clavulanic acid in human plasma by HPLC-ESI mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 1.09

Rational design of 3D dendritic TiO2 nanostructures with favorable architectures. J Am Chem Soc (2011) 1.09

A common origin of complex life cycles in parasitic flatworms: evidence from the complete mitochondrial genome of Microcotyle sebastis (Monogenea: Platyhelminthes). BMC Evol Biol (2007) 1.08

Intrinsic mechanisms of memristive switching. Nano Lett (2011) 1.07

Rosiglitazone ameliorates cisplatin-induced renal injury in mice. Nephrol Dial Transplant (2006) 1.07

Aspiration thrombectomy of acute complete carotid bulb occlusion. J Vasc Interv Radiol (2005) 1.07

Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth. Oncol Rep (2011) 1.07

Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial. J Gastroenterol Hepatol (2012) 1.06

Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors. Oncogene (2005) 1.06

The effect of cognitive behavior therapy-based "forest therapy" program on blood pressure, salivary cortisol level, and quality of life in elderly hypertensive patients. Clin Exp Hypertens (2011) 1.06

Gene inactivation using the CRISPR/Cas9 system in the nematode Pristionchus pacificus. Dev Genes Evol (2014) 1.05

COMP-angiopoietin-1 decreases lipopolysaccharide-induced acute kidney injury. Kidney Int (2009) 1.05

TALEN-based knockout library for human microRNAs. Nat Struct Mol Biol (2013) 1.05

Identification and use of zinc finger transcription factors that increase production of recombinant proteins in yeast and mammalian cells. Biotechnol Prog (2005) 1.05

Prioritizing PubMed articles for the Comparative Toxicogenomic Database utilizing semantic information. Database (Oxford) (2012) 1.05